National University of Singapore, YLL School of Medicine, Singapore; National University Hospital, Division of Rheumatology, University Medicine Cluster, 119228, Singapore; Experimental Dermatology, Institute of Medical Biology, Agency for Science Technology & Research (A*STAR), 138648, Singapore.
Ampang Puteri Specialist Hospital, Orthopaedic Surgery, Selangor, Malaysia.
Int J Surg. 2017 Aug;44:260-268. doi: 10.1016/j.ijsu.2017.06.073. Epub 2017 Jun 23.
Of the many antimicrobial agents available, iodophore-based formulations such as povidone iodine have remained popular after decades of use for antisepsis and wound healing applications due to their favorable efficacy and tolerability. Povidone iodine's broad spectrum of activity, ability to penetrate biofilms, lack of associated resistance, anti-inflammatory properties, low cytotoxicity and good tolerability have been cited as important factors, and no negative effect on wound healing has been observed in clinical practice. Over the past few decades, numerous reports on the use of povidone iodine have been published, however, many of these studies are of differing design, endpoints, and quality. More recent data clearly supports its use in wound healing.
Based on data collected through PubMed using specified search criteria based on above topics and clinical experience of the authors, this article will review preclinical and clinical safety and efficacy data on the use of povidone iodine in wound healing and its implications for the control of infection and inflammation, together with the authors' advice for the successful treatment of acute and chronic wounds.
Povidone iodine has many characteristics that position it extraordinarily well for wound healing, including its broad antimicrobial spectrum, lack of resistance, efficacy against biofilms, good tolerability and its effect on excessive inflammation. Due to its rapid, potent, broad-spectrum antimicrobial properties, and favorable risk/benefit profile, povidone iodine is expected to remain a highly effective treatment for acute and chronic wounds in the foreseeable future.
在众多可用的抗菌剂中,基于碘的制剂,如聚维酮碘,经过数十年的应用,因其良好的疗效和耐受性,在消毒和伤口愈合方面仍然很受欢迎。聚维酮碘的广谱活性、穿透生物膜的能力、无相关耐药性、抗炎特性、低细胞毒性和良好的耐受性被认为是重要因素,在临床实践中没有观察到对伤口愈合的负面影响。在过去的几十年里,已经发表了许多关于聚维酮碘使用的报告,然而,这些研究中的许多研究在设计、终点和质量上都存在差异。最近的数据清楚地支持了其在伤口愈合中的应用。
根据上述主题和作者的临床经验,通过 PubMed 收集的数据,并使用指定的搜索标准,本文将回顾聚维酮碘在伤口愈合中的临床前和临床安全性和疗效数据,以及其在控制感染和炎症方面的应用,同时作者还为急性和慢性伤口的成功治疗提供了建议。
聚维酮碘具有许多特性,使其非常适合伤口愈合,包括其广谱抗菌谱、无耐药性、对生物膜的疗效、良好的耐受性和对过度炎症的影响。由于其快速、强效、广谱的抗菌特性以及良好的风险/获益状况,预计在可预见的未来,聚维酮碘仍将是治疗急性和慢性伤口的一种非常有效的方法。